Prolongation of coronavirus outbreak in China could hit Indian pharma sector
Posted by
www.biotecnika.org
China accounted for 67.56 per cent of total imports of bulk drugs and
drug intermediates in 2018-19 at USD 2,405.42 million. "The situation
is being closely monitored by all companies. The government is seized
of the issue and all are working in an integrated way to deal with the
situation." Indian Pharmaceutical Alliance (IPA) Secretary General
Sudarshan Jain told PTI.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/prolongation-of-coronavirus-outbreak-in-china-could-hit-indian-pharma-sector/articleshow/74040748.cms
Subscribe to:
Post Comments (Atom)
Post a Comment